← Leaderboards
Edward J Shillitoe
Upstate Medical University
$1,946,472
Attributed
$1,946,472
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $235.5K · FY2008–09$250K$187.5K$125K$62.5K$0
'08
'09
Funding mix
By agency
NIH$1,946,472 · 3
By mechanism
R01$1,514,722 · 2
R21$431,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Upstate Medical University
Same institution · by research overlap
- David R Mitchell$3,618,536
- Charles Bih-Chen Hwang$2,405,336
- Steven J Scheinman$1,549,625
- David C Amberg$3,825,974
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellMutantTissue /Cell CultureDisease /Disorder ModelTransfection /Expression VectorVirus GeneticsGene TherapyAthymic MouseOral Pharyngeal NeoplasmGene ExpressionCytotoxicityCytokineGanciclovirVirus ReplicationNonhuman Therapy EvaluationGenetic StrainNeoplastic GrowthMolecular CloningImmune Tolerance /UnresponsivenessHerpes Simplex Virus 1Genetic Promoter ElementNeoplasm /Cancer TherapyPolymerase Chain ReactionCytotoxic Agent
Grant awards (8)
Treatment of oral cancer by herpes simplex virus$196,250
R21 · FY2009 · DE · contact PI
Treatment of oral cancer by herpes simplex virus$235,500
R21 · FY2008 · DE · contact PI
HERPES SIMPLEX VIRUS IN THE TREATMENT OF ORAL CANCER$257,210
R01 · FY2004 · DE
HERPES SIMPLEX VIRUS IN THE TREATMENT OF ORAL CANCER$257,210
R01 · FY2003 · DE
HERPES SIMPLEX VIRUS IN THE TREATMENT OF ORAL CANCER$257,210
R01 · FY2002 · DE
HERPES SIMPLEX VIRUS IN THE TREATMENT OF ORAL CANCER$257,210
R01 · FY2001 · DE
HERPES SIMPLEX VIRUS IN THE TREATMENT OF ORAL CANCER$257,210
R01 · FY2000 · DE
INHIBITION OF PAPILLOMAVIRUSES IN ORAL EPITHELIUM$228,672
R01 · FY2000 · DE